Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
465 GBX | 0.00% | 0.00% | +27.40% |
Apr. 24 | EDX Medical to begin trading on Apex segment of AQSE next week | AN |
Apr. 23 | Marula reaches "significant milestone" for Tanzanian graphite projects | AN |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company's enterprise value to sales, at 4.72 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.40% | 154M | - | ||
+1.43% | 76.28B | B | ||
+24.69% | 23.72B | C+ | ||
+22.73% | 11.95B | C+ | ||
+2.11% | 8.29B | B- | ||
+32.01% | 8.04B | C+ | ||
+22.01% | 4.58B | C | ||
-2.88% | 2.94B | C+ | ||
+17.48% | 2.39B | C | ||
-15.00% | 1.57B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AQX Stock
- Ratings Aquis Exchange PLC